Dosing & Administration

Simplify Care With Flexible
IV and Oral Dosing

Initiate with IV or oral BAXDELA

image of iv vial and syringe

Start on IV

image of pill container and pill

Start on oral

image of iv vial and pill container

Start on IV and
switch to oral

Convenient q12h Dosing Options for 5 to 14 Days

  • 300-mg IV infusion administered over 1 hour q12h
    • Provided as a lyophilized powder in vials
  • 450-mg tablet q12h

No Dosage Adjustment Required Due To:

image group referencing age(adult), weight, sex
image group referencing mild to moderate renal disease, hepatic disease

Fixed-Dosage Adjustment in IV Formulation for Patients with Severe Renal Impairment (eGFR 15-29 mL/min/1.73 m2)

  • IV 200 mg q12h


  • 200 mg IV q12h, then switch to a 450-mg BAXDELA tablet orally q12h at the discretion of the physician
  • BAXDELA is not recommended in patients with ESRD due to insufficient information for dosing recommendations
BAXDELA is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria.